
10x Genomics, Inc. (TXG)
10x Genomics, Inc. does not pay dividends currently đ
They might in the future, check back soon!
About 10x Genomics, Inc.
10x Genomics, Inc. is a biotechnology company that was founded in 2012 and is headquartered in Pleasanton, California. Specializing in innovative genomic technologies, the company develops tools that help researchers examine biological processes at an unprecedented level of resolution, particularly through single-cell and spatial genomics. As of 2023, Serge Saxonov serves as the CEO, co-founding the company with Ben Hindson. Known for its Chromium and Visium systems, 10x Genomics plays an essential role in advancing biomedical research and precision health solutions. The company has been rapidly growing in recent years, marked by significant revenue gains and expansions in its product portfolio, which makes it a key player in the genomics space.